name
Ablynxhomepage url
www.ablynx.comcountry
Belgiumsector
Healthcare & Health Servicesindustry
Biotechnology
Description
Ablynx develops NANOBODY® technology, which enables the creation of new therapeutics and the refinement of existing treatments. The technology utilizes miniature, engineered antibodies derived from camelids, allowing for the design of multi-targeting therapies.
